Statistics for Novel HER2-based multi-epitope vaccine (HER2-MEV) against HER2-positive breast cancer: In silico design and validation

Total visits

views
Novel HER2-based multi-epitope vaccine (HER2-MEV) against HER2-positive breast cancer: In silico design and validation 4

Total visits per month

views
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 4
March 2025 0
April 2025 0